22.445 CASOS INDIVIDUALES DE EFECTOS ADVERSOS CON ORIGEN EN ESPAÑA RECOGIDOS EN EUDRAVIGILANCE (8/02/2026) PARA COVID-19 VACCINE MODERNA (ELASOMERAN)
CASOS INDIVIDUALES EN EUDRAVIGILLANCE
PAÍSES
BLOOD AND LYMPHATIC SYSTEM DISORDERS
THROMBOCYTOPENIA
CARDIAC DISORDERS
MYOCARDITIS
EYE DISORDERS
RETIRADA POR LA COMISIÓN EUROPEA DE LA AUTORIZACIÓN DE LA VACUNA Vaxzevria - COVID-19 (AstraZeneca)
18.246 CASOS INDIVIDUALES DE EFECTOS ADVERSOS CON ORIGEN EN ESPAÑA RECOGIDOS EN EUDRAVIGILANCE (8/02/2026) PARA COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
PAÍSES
BLOOD AND LYMPHATIC SYSTEM DISORDERS
THROMBOCYTOPENIA
CARDIAC DISORDERS
MYOCARDITIS
EYE DISORDERS
— Guillermo Ruiz Zapatero (@ruiz_zapatero) February 9, 2026
2.555 CASOS INDIVIDUALES DE EFECTOS ADVERSOS CON ORIGEN EN ESPAÑA RECOGIDOS EN EUDRAVIGILANCE (8/02/2026) PARA COVID-19 VACCINE JANSSEN (AD26.COV2.S)
The Janssen data in the EudraVigilance database has gone missing.
If you head to the EudraVigilance - European database of suspected adverse drug reaction reports, you will land on the page screenshot below where you will be apprised of the missing data (purple box).
There is a long list of COVID-19 products listed here along with their associated reported adverse events. Janssen is missing.
Here’s what the Wayback Machine found on June 9, 2023 - just 10 days ago.
Unfortunately, we cannot access the actual adverse event data as the URLs are not archived. But I do have a screenshot of the reported adverse events from a query on June 12, 2023. There were N = 69,103 reports for the Janssen products.
So due to technical difficulties, N = 69,103 of your reports are missing from EudraVigilance including many reports involving Nervous system disorders and Musculoskeletal and connective tissue disorders.
